| 1 |
Cura Y, Pérez-ramírez C, Sánchez-martín A, Membrive-jimenez C, Valverde-merino MI, González-flores E, Morales AJ. Influence of Single-Nucleotide Polymorphisms on Clinical Outcomes of Capecitabine-Based Chemotherapy in Colorectal Cancer Patients: A Systematic Review. Cancers 2023;15:1821. [DOI: 10.3390/cancers15061821] [Reference Citation Analysis]
|
| 2 |
Soman A, Asha Nair S. Unfolding the cascade of SERPINA3: Inflammation to cancer. Biochim Biophys Acta Rev Cancer 2022;1877:188760. [PMID: 35843512 DOI: 10.1016/j.bbcan.2022.188760] [Reference Citation Analysis]
|
| 3 |
Connell CM, Brais R, Whitaker H, Upponi S, Beh I, Risdall J, Corrie P, Janowitz T, Jodrell DI. Early relapse on adjuvant gemcitabine associated with an exceptional response to 2nd line capecitabine chemotherapy in a patient with pancreatic adenosquamous carcinoma with strong intra-tumoural expression of cytidine deaminase: a case report. BMC Cancer 2020;20:38. [PMID: 31941506 DOI: 10.1186/s12885-020-6516-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 4 |
Qin F, Zhang H, Huang Y, Yang L, Yu F, Liu X, Fu L, Gu F, Ma Y. Effect of dihydropyrimidine dehydrogenase single nucleotide polymorphisms on prognosis of breast cancer patients with chemotherapy. Oncotarget 2017;8:112060-75. [PMID: 29340111 DOI: 10.18632/oncotarget.23033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 5 |
Tan Y, Tan Y, Lu L, Zhang H, Sun C, Liang Y, Zeng J, Yang X, Li D, Zou H. HPCDb: an integrated database of pancreatic cancer.. [DOI: 10.1101/169771] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 6 |
Mosse I, Kilchevsky A, Nikolova N, Zhelev N. Some problems and errors in cytogenetic biodosimetry. Biotechnology & Biotechnological Equipment 2017;31:460-8. [DOI: 10.1080/13102818.2016.1259018] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 7 |
Natarajan K, Baer MR, Ross DD. Role of Breast Cancer Resistance Protein (BCRP, ABCG2) in Cancer Outcomes and Drug Resistance. Resistance to Targeted Anti-Cancer Therapeutics 2015. [DOI: 10.1007/978-3-319-09801-2_3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 8 |
Wan H, Zhu J, Chen F, Xiao F, Huang H, Han X, Zhong L, Zhong H, Xu L, Ni B, Zhong J. SLC29A1 single nucleotide polymorphisms as independent prognostic predictors for survival of patients with acute myeloid leukemia: an in vitro study. J Exp Clin Cancer Res 2014;33:90. [PMID: 25398670 DOI: 10.1186/s13046-014-0090-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 9 |
Pang L, Word B, Xu J, Wang H, Hammons G, Huang SM, Lyn-Cook B. ATP-Binding Cassette Genes Genotype and Expression: A Potential Association with Pancreatic Cancer Development and Chemoresistance? Gastroenterol Res Pract 2014;2014:414931. [PMID: 24883056 DOI: 10.1155/2014/414931] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 10 |
Hill KS, Gaziova I, Harrigal L, Guerra YA, Qiu S, Sastry SK, Arumugam T, Logsdon CD, Elferink LA. Met receptor tyrosine kinase signaling induces secretion of the angiogenic chemokine interleukin-8/CXCL8 in pancreatic cancer. PLoS One 2012;7:e40420. [PMID: 22815748 DOI: 10.1371/journal.pone.0040420] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 11 |
Schmidt VA. Watch the GAP: Emerging Roles for IQ Motif-Containing GTPase-Activating Proteins IQGAPs in Hepatocellular Carcinoma. Int J Hepatol 2012;2012:958673. [PMID: 22973521 DOI: 10.1155/2012/958673] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
|
